their integrity cannot be compromised. Yet every time physicians accept a fee or other incentive for performing certain tests and procedures, for channeling some of their patients into clinical trials, or for prescribing a new, expensive drug that is not better or safer than an older one, they are balancing their patients’ welfare against their own financial concerns. Their blind spot helps them tip the balance in their own favor, and then justify it: “If a pharmaceutical company wants to give us pens, notepads, calendars, lunches, honoraria, or small consulting fees, why not? We can’t be
...more